ATLANTA, Feb. 25, 2011 /PRNewswire/ -- Elekta's MOSAIQ®* oncology electronic medical record (EMR) has received complete EMR certification. Complete EMR certification officially validates the Elekta ...
ATLANTA, June 3, 2011 /PRNewswire/ -- Elekta's MOSAIQ® oncology electronic medical record (EMR) – the first and only oncology-specific comprehensive EMR to receive complete certification under the ...
“Integrating MOSAIQ and TrueBeam was only the critical first step,” says Todd Powell, Executive Vice President, Elekta Software. “This connectivity has facilitated ongoing additional functionality ...
ATLANTA, Jan. 7, 2013 /PRNewswire/ -- As part of a process to completely integrate the patient's electronic medical record (EMR) with treatment planning activities, Elekta has introduced MOSAIQ® ...
"When configured for radiation oncology, MOSAIQ connects to virtually any planning, imaging, or treatment device, eliminating the forced dependency on any single equipment vendor and providing an ...
BOSTON--(BUSINESS WIRE)--Elekta (STO:EKTAB) is showcasing its MOSAIQ® Oncology Informatics software platform at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, taking place ...
ATLANTA, May 10, 2012 /PRNewswire/ -- Users of Elekta's MOSAIQ® Oncology Information System (OIS) – the first comprehensive, oncology-specific EMR certified for meaningful use under the federal ...
MOSAIQ-microSelectron Digital connectivity is the latest in Elekta's long history of providing interfaces with virtually any radiotherapy delivery device or treatment planning system. Recently, St.
Elekta has introduced MOSAIQ Oncology Informatics software platform at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting. MOSAIQ is a comprehensive, open EMR designed to meet the ...
- From single workstation, U.K. center coordinates advanced IGRT therapy for patients with cancer Delivering Image Guided Radiation Therapy (IGRT) effectively and safely involves careful coordination ...
The MosaiQ AiPlex VAS multiplex assay is designed to simultaneously detect three autoantibody markers - MPO, PR3, and GBM - using only 10 µl of patient serum. The assay runs on the MosaiQ instrument ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results